Trump signs the long executive order that he claims will reduce drug prices

The costs of the drugs prescribed in the United States were out of control over the ages, and they were getting worse. But after the weekend on “embarrassing” drug prices in the United States, President Donald Trump Fell Wide executive claimed that he would reduce drug prices worldwide by reviving a controversial policy since his first term.

On Sunday, Trump announced his plans in Prolonged On the social truth, it was written that the costs of high medicines for the United States “were always difficult to explain and burn.” According to the US Department of Health and Humanitarian Services, the costs of prescribed medicines 15.2 % increased Between January 2022 and January 2023, last year, the Rand report found that the prices of medicines prescribed in the United States revolve around 2.78 times higher From those in 33 other countries.

In his position, Trump stated that he is the new Executive order It will “almost immediately” reduce the costs of drugs by 30 to 80 percent and provide American “trillion dollars”.

“They will rise all over the world for equality, and for the first time in many years, they bring fairness to America!” Trump wrote. “I will put the most preferred country policy as (the United States) will pay the same price of the nation that pays the lowest price anywhere in the world. Our country will be treated fairly, and health care costs will be reduced to our citizens with numbers that you have not thought about before.”

For every Barons, a White House official He said The Minister of National Health Services Robert F. will be directed. Kennedy to facilitate, when necessary, directly to consumer sales in the prices of the favorite nation “and” set clear goals to reduce prices “to open negotiations. If companies do not make progress in these goals, HHS will impose the prices of the most preferred nation by setting rules.” When asked about the insurance market, the official only said, “We are again looking for price discounts for people in all markets, including commercial insurance and federal motives.”

In addition, the US Federal Trade Committee is directed to take measures against anti -competition practices. Reuters I mentioned On Monday, a White House official said, “We are all familiar with some places where pharmaceutical companies are pushing the borders to prevent competition that will reduce their prices,” such as protecting patents or contracting deals with public companies.

Although Trump made great promises about this latest proposal, it is likely to be just a modern. Arthur Kaplan, Head of the Medical Ethics Department at the New York University Center for Medical, I told NBC News, “We will not get the price paid by South Africa, Peru, Egypt, Bolivia and Laos, and pharmaceutical companies usually offer discounts for very poor countries on a humanitarian basis … Prices paid in the poorest countries do not have an opportunity to be the price paid by the Trump administration.”

In addition, experts at the Chevir Institute at the University of South California last month warned that most of the nation’s policies were easily preferred. They also indicated that companies may simply withdraw from foreign markets to lock prices in the United States because the United States compensates About 70 % of global pharmaceutical profits.

During his first term, Trump tried to implement the policy of the most preferred countries that was It was banned in the end By a federal judge. However, NBC News reported that experts in this field have said that Trump’s new policy is more aggressive than his previous attempt. For example, some medications will not be limited to medical care, but it will also be applied to those covered by Medicaid and special insurance.

The new executive of Trump comes after him I signed a request at the end of last month Those steps that will be taken by the federal government to reduce drug prices. But even those proposals were “all the bark and no bite”, according to the Senator Ron Wadeen, a member of the Senate Finance Committee.

Oiden also Condemn Trump has commanded the previous “widespread things that Big Pharma begged by weakening negotiations on medical care”, a program that belongs to the Biden era that allows the federal government to negotiate directly with pharmaceutical companies. He added: “The Democrats invented the drug negotiation body in Medicare without a single Republican vote – it’s time now for Trump to follow the law honestly that Congress passed without watering it at the request of Big Pharma.”

Ultimately, it is not clear what Trump’s new executive effect on drug costs, or whether he will face a decline in the courts. But at the same time that Trump climbed about the costs of drugs online, Republicans in the House of Representatives MEDICAID It would cost millions of people to secure them.